Neurological Functional Capacity Assessments for NDIS Participants

Participants with neurological conditions present uniquely complex functional profiles — combining motor, cognitive, behavioural, fatigue and self-management impairments in ways that vary dramatically across individuals and across time. A generic FCA often captures only one dimension of this complexity. The result is a report that may justify physical supports but miss the cognitive load drivers, or vice versa.

A specialised neurological FCA integrates all of these dimensions into a single coherent functional narrative. Whether the participant lives with acquired brain injury, multiple sclerosis, Parkinson's disease, stroke, motor neurone disease, spinal cord injury, Huntington's disease or another neurological condition, our assessment framework is built to capture the full functional picture rather than a partial view.

Our neurological FCAs are led by experienced AHPRA-registered Occupational Therapists with specific clinical training in neurological rehabilitation, supported by multidisciplinary clinical oversight from our Director team. This matters because neurological function cannot be cleanly separated into 'physical' and 'cognitive' boxes. Mobility limitations interact with fatigue. Cognitive impairment shapes self-management of medication and appointments. Behavioural changes after brain injury affect community participation. A clinician trained across these dimensions produces a more accurate, more integrated assessment than a clinician focused on a single domain.

Our multidisciplinary leadership gives us specific depth across mobility analysis, transfer mechanics, falls and risk assessment, fatigue profiling, pain interaction with function, and assistive technology and equipment justification — alongside cognitive, sensory and psychosocial considerations critical for neurological participants.

Many neurological conditions are progressive — MS, Parkinson's, MND, Huntington's, dementia — and others are characterised by significant day-to-day variability (fatigue cycles in MS, ON/OFF periods in Parkinson's, post-stroke fatigue patterns). A point-in-time assessment cannot adequately capture either dimension.

Our neurological FCAs deliberately profile both trajectory and variability. For progressive conditions, we document current function alongside expected six-month and twelve-month deterioration windows, allowing the funding package to anticipate change rather than chase it. For variable conditions, we document functioning across good days, average days and difficult days, so the planner understands the genuine range rather than a single snapshot.

The Care and Needs Scale was developed at the University of Sydney for adults with acquired brain injury and has since become a recognised tool across high-support neurological cohorts. The CANS rates supervision and care intensity on an 8-point ordinal scale, from no support required (CANS 1) through to 24-hour care with two attendants (CANS 8).

We use the CANS as a complement to domain-by-domain functional assessment for participants with ABI, severe MS, late-stage Parkinson's, post-stroke high-support profiles and other neurological conditions where supervision intensity is the dominant funding driver. The CANS provides a recognised, defensible anchor for SIL ratio recommendations — CANS 5–6 typically maps to 1:1 daytime support, while CANS 7–8 maps to 2:1 or active overnight arrangements.

Many neurological participants experience cognitive impairment (memory, executive function, processing speed, attention) and behavioural change (impulsivity, disinhibition, emotional dysregulation, lack of insight). These dimensions are critical funding drivers but are routinely under-documented in generic FCAs.

Our neurological FCAs include explicit cognitive and behavioural profiling. Where appropriate, we integrate findings from neuropsychological assessment, behaviour support plans and treating-team observation. We document the practical functional consequences of cognitive impairment — for example, the inability to safely manage medication independently, the need for prompting around appointments, or the risk of community wandering — and link these directly to recommended supports.

Neurological participants frequently require complex assistive technology — powered wheelchairs, communication devices, environmental control units, hoists, pressure care, vehicle modifications. Our neurological FCAs include AT assessment components that link each piece of equipment to specific functional need, comparative options analysis where required, and trial documentation where relevant.

This integrated approach is significantly more efficient for the participant than commissioning separate FCA and AT reports. Where the AT requirement is straightforward, it can be addressed within the neurological FCA. Where complex AT requires standalone justification, we coordinate the assessments so the evidence tells one coherent story.